| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pre-Eclampsia | 11 | 2024 | 270 | 3.120 |
Why?
|
| Hypertension, Pregnancy-Induced | 7 | 2024 | 89 | 2.230 |
Why?
|
| Activins | 4 | 2022 | 23 | 2.050 |
Why?
|
| Cardiomyopathies | 9 | 2024 | 315 | 1.830 |
Why?
|
| Echocardiography | 13 | 2021 | 783 | 1.680 |
Why?
|
| Postpartum Period | 6 | 2025 | 169 | 1.670 |
Why?
|
| Patient Readmission | 4 | 2019 | 425 | 1.640 |
Why?
|
| Ventricular Function, Left | 4 | 2022 | 540 | 1.460 |
Why?
|
| Heart Diseases | 5 | 2024 | 268 | 1.380 |
Why?
|
| Pregnancy | 25 | 2025 | 3246 | 1.310 |
Why?
|
| Sepsis | 5 | 2018 | 401 | 1.260 |
Why?
|
| Heart Ventricles | 4 | 2021 | 664 | 1.220 |
Why?
|
| Pregnancy Complications, Cardiovascular | 3 | 2017 | 111 | 1.080 |
Why?
|
| Follistatin-Related Proteins | 2 | 2025 | 11 | 1.040 |
Why?
|
| Perioperative Care | 7 | 2022 | 196 | 1.030 |
Why?
|
| Puerperal Disorders | 2 | 2025 | 36 | 0.970 |
Why?
|
| Ventricular Dysfunction, Left | 3 | 2019 | 264 | 0.910 |
Why?
|
| Blood Pressure | 4 | 2018 | 909 | 0.900 |
Why?
|
| Anesthesiology | 8 | 2022 | 171 | 0.880 |
Why?
|
| Opioid-Related Disorders | 2 | 2019 | 255 | 0.840 |
Why?
|
| Shock, Cardiogenic | 3 | 2018 | 183 | 0.820 |
Why?
|
| Peripartum Period | 3 | 2024 | 30 | 0.790 |
Why?
|
| Stroke Volume | 3 | 2022 | 464 | 0.750 |
Why?
|
| Biomedical Research | 2 | 2018 | 470 | 0.730 |
Why?
|
| Humans | 78 | 2025 | 97883 | 0.720 |
Why?
|
| Hypertension | 5 | 2024 | 778 | 0.690 |
Why?
|
| Critical Care | 4 | 2020 | 462 | 0.680 |
Why?
|
| Biomarkers | 8 | 2025 | 2016 | 0.680 |
Why?
|
| Shock, Septic | 4 | 2018 | 135 | 0.680 |
Why?
|
| Cardiovascular Diseases | 2 | 2025 | 802 | 0.640 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 4 | 2018 | 111 | 0.630 |
Why?
|
| Prospective Studies | 17 | 2024 | 4798 | 0.630 |
Why?
|
| Female | 41 | 2025 | 51464 | 0.620 |
Why?
|
| Adult | 30 | 2025 | 29453 | 0.620 |
Why?
|
| Severity of Illness Index | 3 | 2016 | 2008 | 0.620 |
Why?
|
| Retrospective Studies | 20 | 2024 | 10947 | 0.620 |
Why?
|
| Myocardial Contraction | 1 | 2021 | 193 | 0.620 |
Why?
|
| Inpatients | 2 | 2020 | 367 | 0.610 |
Why?
|
| Decision Support Techniques | 2 | 2021 | 194 | 0.610 |
Why?
|
| Prenatal Care | 1 | 2020 | 81 | 0.600 |
Why?
|
| Length of Stay | 4 | 2018 | 869 | 0.580 |
Why?
|
| Aspirin | 1 | 2020 | 168 | 0.580 |
Why?
|
| Palpation | 1 | 2018 | 19 | 0.570 |
Why?
|
| Critical Illness | 2 | 2019 | 360 | 0.560 |
Why?
|
| Echocardiography, Three-Dimensional | 5 | 2015 | 339 | 0.550 |
Why?
|
| Publication Bias | 1 | 2017 | 18 | 0.520 |
Why?
|
| Respiratory Insufficiency | 1 | 2020 | 204 | 0.520 |
Why?
|
| Fluid Therapy | 1 | 2018 | 68 | 0.520 |
Why?
|
| Pregnancy Complications | 3 | 2017 | 365 | 0.520 |
Why?
|
| Lung Injury | 1 | 2018 | 61 | 0.510 |
Why?
|
| Editorial Policies | 1 | 2017 | 37 | 0.510 |
Why?
|
| Endoglin | 1 | 2017 | 22 | 0.510 |
Why?
|
| Biostatistics | 1 | 2017 | 21 | 0.500 |
Why?
|
| Aortic Aneurysm | 1 | 2017 | 72 | 0.500 |
Why?
|
| Blood Loss, Surgical | 1 | 2017 | 140 | 0.490 |
Why?
|
| Blood Transfusion | 1 | 2017 | 179 | 0.480 |
Why?
|
| Evidence-Based Medicine | 2 | 2021 | 478 | 0.470 |
Why?
|
| Angiogenic Proteins | 1 | 2016 | 16 | 0.470 |
Why?
|
| Hospital Mortality | 2 | 2018 | 518 | 0.460 |
Why?
|
| Databases, Factual | 5 | 2018 | 1094 | 0.460 |
Why?
|
| Heart | 3 | 2017 | 527 | 0.440 |
Why?
|
| Young Adult | 11 | 2020 | 7504 | 0.440 |
Why?
|
| Pharmacogenetics | 5 | 2022 | 472 | 0.440 |
Why?
|
| Pharmacogenomic Testing | 3 | 2021 | 119 | 0.430 |
Why?
|
| Echocardiography, Transesophageal | 7 | 2018 | 266 | 0.430 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2017 | 246 | 0.430 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2019 | 983 | 0.420 |
Why?
|
| Hospitals, High-Volume | 1 | 2015 | 47 | 0.420 |
Why?
|
| Pregnancy Outcome | 4 | 2018 | 278 | 0.410 |
Why?
|
| Research Design | 1 | 2018 | 650 | 0.400 |
Why?
|
| Aortic Valve Stenosis | 2 | 2012 | 155 | 0.400 |
Why?
|
| Risk Factors | 10 | 2021 | 6224 | 0.390 |
Why?
|
| Hospitals | 2 | 2021 | 335 | 0.390 |
Why?
|
| Heart Failure | 2 | 2024 | 1491 | 0.360 |
Why?
|
| Endovascular Procedures | 1 | 2017 | 398 | 0.360 |
Why?
|
| Hospitalization | 2 | 2015 | 982 | 0.350 |
Why?
|
| Heart-Assist Devices | 1 | 2019 | 916 | 0.340 |
Why?
|
| Anesthesia | 3 | 2022 | 175 | 0.330 |
Why?
|
| Case-Control Studies | 4 | 2020 | 1995 | 0.320 |
Why?
|
| Adolescent | 9 | 2018 | 10078 | 0.320 |
Why?
|
| Aged, 80 and over | 8 | 2018 | 7386 | 0.310 |
Why?
|
| Cardiac Surgical Procedures | 5 | 2018 | 508 | 0.300 |
Why?
|
| Aged | 16 | 2019 | 21702 | 0.300 |
Why?
|
| Image Enhancement | 1 | 2012 | 503 | 0.300 |
Why?
|
| Cohort Studies | 6 | 2018 | 3202 | 0.290 |
Why?
|
| Multivariate Analysis | 3 | 2017 | 1009 | 0.290 |
Why?
|
| United States | 7 | 2019 | 8184 | 0.280 |
Why?
|
| Treatment Outcome | 8 | 2022 | 9682 | 0.270 |
Why?
|
| Middle Aged | 14 | 2019 | 29353 | 0.260 |
Why?
|
| Internship and Residency | 5 | 2019 | 1120 | 0.250 |
Why?
|
| Operating Rooms | 2 | 2019 | 144 | 0.250 |
Why?
|
| Intra-Aortic Balloon Pumping | 2 | 2019 | 100 | 0.240 |
Why?
|
| Vasoconstrictor Agents | 2 | 2017 | 71 | 0.240 |
Why?
|
| Time Factors | 3 | 2021 | 5555 | 0.240 |
Why?
|
| Logistic Models | 4 | 2017 | 1273 | 0.230 |
Why?
|
| Male | 20 | 2022 | 46992 | 0.230 |
Why?
|
| Postnatal Care | 3 | 2024 | 32 | 0.230 |
Why?
|
| Predictive Value of Tests | 4 | 2021 | 1778 | 0.230 |
Why?
|
| Mitral Valve Insufficiency | 3 | 2011 | 179 | 0.220 |
Why?
|
| Clinical Competence | 4 | 2016 | 863 | 0.220 |
Why?
|
| Intensive Care Units | 2 | 2019 | 473 | 0.210 |
Why?
|
| Curriculum | 3 | 2019 | 633 | 0.210 |
Why?
|
| Communication | 2 | 2019 | 455 | 0.210 |
Why?
|
| Labor, Obstetric | 2 | 2022 | 49 | 0.210 |
Why?
|
| Placenta | 2 | 2024 | 202 | 0.200 |
Why?
|
| Anesthetics, Inhalation | 1 | 2024 | 97 | 0.200 |
Why?
|
| Sex Work | 1 | 2002 | 13 | 0.190 |
Why?
|
| Cesarean Section | 3 | 2018 | 162 | 0.190 |
Why?
|
| Occupational Exposure | 1 | 2024 | 99 | 0.190 |
Why?
|
| Preoperative Care | 2 | 2017 | 418 | 0.180 |
Why?
|
| Monitoring, Intraoperative | 3 | 2018 | 115 | 0.180 |
Why?
|
| Tramadol | 1 | 2022 | 14 | 0.180 |
Why?
|
| Analgesia, Obstetrical | 1 | 2022 | 24 | 0.180 |
Why?
|
| Mitral Valve | 3 | 2012 | 229 | 0.180 |
Why?
|
| Postoperative Complications | 5 | 2020 | 2680 | 0.180 |
Why?
|
| Prognosis | 4 | 2021 | 4112 | 0.180 |
Why?
|
| Analgesia, Epidural | 1 | 2022 | 42 | 0.170 |
Why?
|
| Breast Feeding | 2 | 2002 | 113 | 0.170 |
Why?
|
| Airway Management | 1 | 2022 | 48 | 0.170 |
Why?
|
| Follow-Up Studies | 4 | 2021 | 4023 | 0.170 |
Why?
|
| Pharmacogenomic Variants | 1 | 2021 | 46 | 0.170 |
Why?
|
| Respiratory System | 1 | 2022 | 120 | 0.170 |
Why?
|
| Anesthetics | 1 | 2021 | 51 | 0.170 |
Why?
|
| Workload | 1 | 2021 | 130 | 0.160 |
Why?
|
| Follistatin | 1 | 2020 | 7 | 0.160 |
Why?
|
| Intubation, Intratracheal | 1 | 2022 | 160 | 0.160 |
Why?
|
| Placenta Growth Factor | 2 | 2018 | 85 | 0.160 |
Why?
|
| Analgesics | 1 | 2021 | 131 | 0.160 |
Why?
|
| Seasons | 1 | 2021 | 251 | 0.160 |
Why?
|
| Elective Surgical Procedures | 1 | 2021 | 171 | 0.150 |
Why?
|
| Anesthesia Department, Hospital | 1 | 2019 | 8 | 0.150 |
Why?
|
| Transportation of Patients | 1 | 2019 | 36 | 0.150 |
Why?
|
| Incidence | 3 | 2018 | 1776 | 0.150 |
Why?
|
| Clinical Decision-Making | 2 | 2021 | 304 | 0.150 |
Why?
|
| Workflow | 1 | 2019 | 85 | 0.140 |
Why?
|
| Reproducibility of Results | 2 | 2017 | 2783 | 0.140 |
Why?
|
| Pneumonia, Aspiration | 1 | 2018 | 20 | 0.140 |
Why?
|
| Antibodies, Viral | 1 | 2021 | 339 | 0.140 |
Why?
|
| Drug Administration Schedule | 1 | 2020 | 836 | 0.140 |
Why?
|
| Neuromuscular Blocking Agents | 1 | 2018 | 28 | 0.140 |
Why?
|
| Hepatitis C Antibodies | 1 | 1998 | 8 | 0.140 |
Why?
|
| Neuromuscular Blockade | 1 | 2018 | 29 | 0.140 |
Why?
|
| Down-Regulation | 1 | 2020 | 529 | 0.140 |
Why?
|
| Ultrasonography, Interventional | 2 | 2016 | 126 | 0.140 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 1998 | 36 | 0.140 |
Why?
|
| Rats | 2 | 2022 | 4070 | 0.140 |
Why?
|
| Carrier State | 1 | 1998 | 40 | 0.140 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2018 | 72 | 0.140 |
Why?
|
| Intraoperative Care | 1 | 2018 | 90 | 0.140 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2019 | 130 | 0.140 |
Why?
|
| Oxytocics | 1 | 2018 | 26 | 0.130 |
Why?
|
| Leukocytosis | 1 | 2017 | 15 | 0.130 |
Why?
|
| Maternal Health Services | 1 | 2017 | 16 | 0.130 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2017 | 70 | 0.130 |
Why?
|
| Oxytocin | 1 | 2018 | 73 | 0.130 |
Why?
|
| Hospital Costs | 1 | 2018 | 117 | 0.130 |
Why?
|
| Cystectomy | 1 | 2018 | 124 | 0.130 |
Why?
|
| Pain Management | 1 | 2019 | 194 | 0.130 |
Why?
|
| Maternal Mortality | 1 | 2017 | 16 | 0.130 |
Why?
|
| Heart Rate | 2 | 2017 | 534 | 0.130 |
Why?
|
| Prevalence | 2 | 2018 | 1384 | 0.130 |
Why?
|
| Coronary Artery Disease | 1 | 2022 | 387 | 0.120 |
Why?
|
| Chi-Square Distribution | 1 | 2017 | 359 | 0.120 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2019 | 220 | 0.120 |
Why?
|
| Bradycardia | 1 | 2017 | 51 | 0.120 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2017 | 152 | 0.120 |
Why?
|
| Hepatitis C | 1 | 1998 | 186 | 0.120 |
Why?
|
| Sensitivity and Specificity | 2 | 2021 | 1944 | 0.120 |
Why?
|
| Postoperative Care | 1 | 2017 | 236 | 0.120 |
Why?
|
| Ultrasonography | 1 | 2018 | 720 | 0.120 |
Why?
|
| Protamines | 1 | 2015 | 8 | 0.120 |
Why?
|
| Odds Ratio | 1 | 2017 | 724 | 0.110 |
Why?
|
| Hemodynamics | 2 | 2018 | 745 | 0.110 |
Why?
|
| Infant, Newborn | 3 | 2012 | 2529 | 0.110 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 373 | 0.110 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 341 | 0.110 |
Why?
|
| Computer Simulation | 4 | 2016 | 1145 | 0.110 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 337 | 0.110 |
Why?
|
| Robotic Surgical Procedures | 1 | 2022 | 411 | 0.110 |
Why?
|
| Child | 2 | 2020 | 7680 | 0.110 |
Why?
|
| Gestational Age | 1 | 2016 | 340 | 0.110 |
Why?
|
| Comorbidity | 1 | 2018 | 1032 | 0.110 |
Why?
|
| Coronary Artery Bypass | 2 | 2022 | 231 | 0.110 |
Why?
|
| Hospitals, Urban | 1 | 2015 | 66 | 0.110 |
Why?
|
| Pilot Projects | 2 | 2018 | 968 | 0.100 |
Why?
|
| Demography | 1 | 2014 | 193 | 0.100 |
Why?
|
| Thoracic Surgery | 1 | 2015 | 71 | 0.100 |
Why?
|
| Survival Analysis | 1 | 2017 | 1527 | 0.100 |
Why?
|
| Risk Assessment | 2 | 2021 | 2580 | 0.100 |
Why?
|
| HIV Infections | 1 | 2002 | 1018 | 0.100 |
Why?
|
| User-Computer Interface | 2 | 2011 | 194 | 0.090 |
Why?
|
| Neuropeptide Y | 1 | 2012 | 29 | 0.090 |
Why?
|
| Heart Valve Prosthesis Implantation | 2 | 2011 | 192 | 0.090 |
Why?
|
| Learning | 1 | 2016 | 310 | 0.090 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2012 | 30 | 0.090 |
Why?
|
| Chicago | 3 | 2024 | 1513 | 0.090 |
Why?
|
| Coronary Circulation | 1 | 2012 | 97 | 0.090 |
Why?
|
| Patient Care Team | 1 | 2015 | 318 | 0.090 |
Why?
|
| Academic Medical Centers | 1 | 2015 | 407 | 0.090 |
Why?
|
| Coronary Vessel Anomalies | 1 | 2012 | 43 | 0.090 |
Why?
|
| Hypercholesterolemia | 1 | 2012 | 161 | 0.090 |
Why?
|
| Heart Arrest | 1 | 2015 | 315 | 0.090 |
Why?
|
| Pulmonary Edema | 1 | 2011 | 54 | 0.080 |
Why?
|
| Myocardial Ischemia | 1 | 2012 | 142 | 0.080 |
Why?
|
| Tricuspid Valve Stenosis | 1 | 2011 | 4 | 0.080 |
Why?
|
| Animals | 6 | 2024 | 28899 | 0.080 |
Why?
|
| Saphenous Vein | 1 | 2011 | 61 | 0.080 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2011 | 21 | 0.080 |
Why?
|
| Succinylcholine | 2 | 2022 | 14 | 0.080 |
Why?
|
| Aneurysm, False | 1 | 2011 | 52 | 0.080 |
Why?
|
| Abnormalities, Multiple | 1 | 2012 | 235 | 0.080 |
Why?
|
| Neovascularization, Pathologic | 1 | 2012 | 356 | 0.080 |
Why?
|
| ROC Curve | 1 | 2012 | 793 | 0.080 |
Why?
|
| Water-Electrolyte Balance | 1 | 2010 | 70 | 0.080 |
Why?
|
| Cardiopulmonary Bypass | 2 | 2024 | 161 | 0.080 |
Why?
|
| Pulmonary Artery | 1 | 2012 | 342 | 0.080 |
Why?
|
| Coronary Disease | 1 | 2011 | 227 | 0.080 |
Why?
|
| Teaching | 1 | 2010 | 143 | 0.070 |
Why?
|
| Aortic Valve | 1 | 2011 | 258 | 0.070 |
Why?
|
| Myocardial Infarction | 1 | 2011 | 396 | 0.060 |
Why?
|
| Point-of-Care Systems | 2 | 2019 | 155 | 0.050 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 2024 | 39 | 0.050 |
Why?
|
| Blood Pressure Determination | 1 | 2024 | 72 | 0.050 |
Why?
|
| Disease Models, Animal | 3 | 2019 | 2571 | 0.050 |
Why?
|
| Fetal Distress | 1 | 2002 | 11 | 0.050 |
Why?
|
| Infant Welfare | 1 | 2002 | 6 | 0.050 |
Why?
|
| Perfusion | 1 | 2024 | 271 | 0.050 |
Why?
|
| Omeprazole | 1 | 2022 | 11 | 0.050 |
Why?
|
| Hydralazine | 1 | 2022 | 22 | 0.040 |
Why?
|
| Electrocardiography | 2 | 2018 | 527 | 0.040 |
Why?
|
| Surveys and Questionnaires | 2 | 2024 | 3021 | 0.040 |
Why?
|
| Oxycodone | 1 | 2022 | 35 | 0.040 |
Why?
|
| Bupivacaine | 1 | 2022 | 48 | 0.040 |
Why?
|
| Florida | 1 | 2021 | 63 | 0.040 |
Why?
|
| HIV-1 | 1 | 2002 | 179 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2011 | 2666 | 0.040 |
Why?
|
| Texas | 1 | 2021 | 135 | 0.040 |
Why?
|
| Age Distribution | 1 | 2021 | 208 | 0.040 |
Why?
|
| Anesthetics, Local | 1 | 2022 | 85 | 0.040 |
Why?
|
| Evidence-Based Practice | 1 | 2021 | 54 | 0.040 |
Why?
|
| Transcription Factors | 2 | 2024 | 1717 | 0.040 |
Why?
|
| Telemedicine | 1 | 2024 | 250 | 0.040 |
Why?
|
| Fever | 1 | 2022 | 121 | 0.040 |
Why?
|
| Fentanyl | 1 | 2022 | 92 | 0.040 |
Why?
|
| Cross Reactions | 1 | 2021 | 116 | 0.040 |
Why?
|
| Immunoglobulin M | 1 | 2021 | 153 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2012 | 1302 | 0.040 |
Why?
|
| Coronary Angiography | 2 | 2012 | 237 | 0.040 |
Why?
|
| Washington | 1 | 2020 | 51 | 0.040 |
Why?
|
| New York City | 1 | 2020 | 75 | 0.040 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 33 | 0.040 |
Why?
|
| Personnel, Hospital | 1 | 2020 | 31 | 0.040 |
Why?
|
| Laboratories | 1 | 2020 | 47 | 0.040 |
Why?
|
| Insurance, Health | 1 | 2021 | 186 | 0.040 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2020 | 79 | 0.040 |
Why?
|
| Quality Improvement | 1 | 2024 | 520 | 0.040 |
Why?
|
| Pulsatile Flow | 1 | 2019 | 50 | 0.040 |
Why?
|
| Health Resources | 1 | 2020 | 80 | 0.040 |
Why?
|
| Reference Values | 1 | 2020 | 608 | 0.040 |
Why?
|
| Pain | 1 | 2022 | 416 | 0.040 |
Why?
|
| Atracurium | 1 | 2018 | 5 | 0.040 |
Why?
|
| Immunoglobulin G | 1 | 2021 | 480 | 0.040 |
Why?
|
| Colostrum | 1 | 1998 | 2 | 0.040 |
Why?
|
| Health Status Disparities | 1 | 2021 | 234 | 0.030 |
Why?
|
| Milk, Human | 1 | 1998 | 54 | 0.030 |
Why?
|
| Fetal Blood | 1 | 1998 | 94 | 0.030 |
Why?
|
| Organ Dysfunction Scores | 1 | 2018 | 34 | 0.030 |
Why?
|
| Uterus | 1 | 2019 | 231 | 0.030 |
Why?
|
| Simulation Training | 1 | 2019 | 117 | 0.030 |
Why?
|
| Therapeutics | 1 | 2017 | 13 | 0.030 |
Why?
|
| Ischemia | 1 | 2019 | 262 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2021 | 1284 | 0.030 |
Why?
|
| Hepacivirus | 1 | 1998 | 137 | 0.030 |
Why?
|
| RNA, Viral | 1 | 1998 | 287 | 0.030 |
Why?
|
| Leukocyte Count | 1 | 2017 | 214 | 0.030 |
Why?
|
| Pneumonia | 1 | 2018 | 195 | 0.030 |
Why?
|
| Perinatal Care | 1 | 2017 | 23 | 0.030 |
Why?
|
| APACHE | 1 | 2016 | 24 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2019 | 1255 | 0.030 |
Why?
|
| Diagnosis, Differential | 2 | 2011 | 1567 | 0.030 |
Why?
|
| Software | 2 | 2011 | 692 | 0.030 |
Why?
|
| Morbidity | 1 | 2017 | 162 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 1998 | 889 | 0.030 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2018 | 236 | 0.030 |
Why?
|
| Propensity Score | 1 | 2017 | 213 | 0.030 |
Why?
|
| Lung Diseases | 1 | 2018 | 284 | 0.030 |
Why?
|
| Pregnancy Proteins | 1 | 2015 | 37 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2018 | 661 | 0.030 |
Why?
|
| Pregnancy in Diabetics | 1 | 2015 | 43 | 0.030 |
Why?
|
| Genetic Testing | 1 | 2019 | 594 | 0.030 |
Why?
|
| Mice | 2 | 2024 | 12698 | 0.030 |
Why?
|
| Diabetes, Gestational | 1 | 2015 | 51 | 0.030 |
Why?
|
| Models, Anatomic | 1 | 2015 | 88 | 0.030 |
Why?
|
| Precision Medicine | 1 | 2019 | 498 | 0.030 |
Why?
|
| Delphi Technique | 1 | 2015 | 181 | 0.030 |
Why?
|
| Aorta | 1 | 2015 | 275 | 0.030 |
Why?
|
| Pandemics | 1 | 2020 | 913 | 0.030 |
Why?
|
| Attitude of Health Personnel | 1 | 2019 | 684 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2018 | 1946 | 0.030 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2019 | 658 | 0.030 |
Why?
|
| Consensus | 1 | 2015 | 315 | 0.020 |
Why?
|
| Educational Measurement | 1 | 2015 | 241 | 0.020 |
Why?
|
| Echocardiography, Four-Dimensional | 1 | 2012 | 1 | 0.020 |
Why?
|
| Receptors, Neuropeptide Y | 1 | 2012 | 3 | 0.020 |
Why?
|
| Bromocriptine | 1 | 2012 | 12 | 0.020 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2012 | 18 | 0.020 |
Why?
|
| Rupture, Spontaneous | 1 | 2011 | 43 | 0.020 |
Why?
|
| Education, Medical, Graduate | 1 | 2016 | 449 | 0.020 |
Why?
|
| Systole | 1 | 2011 | 81 | 0.020 |
Why?
|
| Ventricular Function, Right | 1 | 2012 | 146 | 0.020 |
Why?
|
| Infant | 1 | 1998 | 3329 | 0.020 |
Why?
|
| Neovascularization, Physiologic | 1 | 2012 | 146 | 0.020 |
Why?
|
| Swine | 1 | 2012 | 591 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2012 | 309 | 0.020 |
Why?
|
| Oxygen | 1 | 2015 | 772 | 0.020 |
Why?
|
| Computer Graphics | 1 | 2010 | 99 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2012 | 400 | 0.020 |
Why?
|
| Anesthesia, General | 1 | 2011 | 129 | 0.020 |
Why?
|
| Catheterization | 1 | 2011 | 219 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2019 | 2555 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2012 | 902 | 0.020 |
Why?
|
| Surgeons | 1 | 2015 | 325 | 0.020 |
Why?
|
| Trans-Activators | 1 | 2012 | 447 | 0.020 |
Why?
|
| Myocytes, Cardiac | 1 | 2012 | 328 | 0.020 |
Why?
|
| Myocardium | 1 | 2012 | 578 | 0.020 |
Why?
|
| Respiratory Mechanics | 1 | 2010 | 109 | 0.020 |
Why?
|
| Cardiac Catheterization | 1 | 2011 | 307 | 0.020 |
Why?
|
| Physicians | 1 | 2016 | 685 | 0.020 |
Why?
|
| Monitoring, Physiologic | 1 | 2010 | 263 | 0.020 |
Why?
|
| Obesity | 1 | 2015 | 1061 | 0.020 |
Why?
|
| Reoperation | 1 | 2011 | 727 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2012 | 2206 | 0.020 |
Why?
|
| Respiration, Artificial | 1 | 2010 | 430 | 0.020 |
Why?
|